Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective

被引:25
作者
Stewart, Suzanne B. [1 ]
Boorjian, Stephen A. [1 ]
机构
[1] Mayo Clin, Dept Urol, Rochester, MN 55905 USA
关键词
Prostate cancer; Prostatectomy; High risk; Treatment; ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; QUALITY-OF-LIFE; RADIATION-THERAPY; CONSERVATIVE TREATMENT; ADJUVANT RADIOTHERAPY; PREDICTING SURVIVAL; MORTALITY OUTCOMES; PLUS ORCHIECTOMY; RANDOMIZED-TRIAL;
D O I
10.1016/j.urolonc.2014.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Men diagnosed with high-risk prostate cancer represent the cohort of prostate cancer patients at greatest risk for subsequent disease-specific mortality. Unfortunately, however, the classification of high-risk tumors remains imprecise and heterogeneous. There has been a historical reluctance to offer such patients aggressive local treatment, and considerable debate exists regarding the optimal management in this setting. Methods: We present here our institutional experience, as well as data from several other centers, with radical prostatectomy for high-risk tumors. Results: We discuss that surgery affords accurate pathological staging, thereby improving the identification of patients for secondary therapies. Moreover, prostatectomy not only provides durable local disease control but in addition numerous contemporary surgical series in high-risk patients have shown radical prostatectomy to be associated with excellent long-term cancer-specific survival. Further, although studies comparing surgical and radiotherapy modalities in high-risk prostate patients have been wrought with methodological challenges, consistently these observational studies have found equivalent to improved oncologic outcomes when surgery is utilized as the primary treatment. Conclusions: Herein, we review the advantages, long-term outcomes, and technique of surgery for high-risk prostate cancer. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 85 条
[71]   Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study [J].
Steuber, Thomas ;
Budaeus, Lars ;
Walz, Jochen ;
Zorn, Kevin C. ;
Schlomm, Thorsten ;
Chun, Felix ;
Ahyai, Sascha ;
Fisch, Margit ;
Sauter, Guido ;
Huland, Hartwig ;
Graefen, Markus ;
Haese, Alexander .
BJU INTERNATIONAL, 2011, 107 (11) :1755-1761
[72]  
Tefilli MV, 1998, J SURG ONCOL, V69, P156, DOI 10.1002/(SICI)1096-9098(199811)69:3<156::AID-JSO7>3.0.CO
[73]  
2-D
[74]   Long-term survival in men with high grade prostate cancer: A comparison between conservative treatment, radiation therapy and radical prostatectomy - A propensity scoring approach [J].
Tewari, Ashutosh ;
Divine, George ;
Chang, Peter ;
Shemtov, M. Mendel ;
Milowsky, Matthew ;
Nanus, David ;
Menon, Mani .
JOURNAL OF UROLOGY, 2007, 177 (03) :911-915
[75]   Guideline for the management of clinically localized prostate cancer: 2007 update [J].
Thompson, Ian ;
Thrasher, James Brantley ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
Cookson, Michael S. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine M. .
JOURNAL OF UROLOGY, 2007, 177 (06) :2106-2131
[76]   Adjuvant radiotherapy for pathologically advanced prostate cancer - A randomized clinical trial [J].
Thompson, Ian M., Jr. ;
Tangen, Catherine M. ;
Paradelo, Jorge ;
Lucia, M. Scott ;
Miller, Gary ;
Troyer, Dean ;
Messing, Edward ;
Forman, Jeffrey ;
Chin, Joseph ;
Swanson, Gregory ;
Canby-Hagino, Edith ;
Crawford, E. David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (19) :2329-2335
[77]   Impact of previous local treatment for prostate cancer on subsequent metastatic disease [J].
Thompson, IM ;
Tangen, C ;
Basler, J ;
Crawford, ED .
JOURNAL OF UROLOGY, 2002, 168 (03) :1008-1012
[78]   The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy [J].
Ward, JF ;
Zincke, H ;
Bergstralh, EJ ;
Slezak, JM ;
Myers, RP ;
Blute, ML .
JOURNAL OF UROLOGY, 2004, 172 (04) :1328-1332
[79]   Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome [J].
Ward, JF ;
Slezak, JM ;
Blute, ML ;
Bergstralh, EJ ;
Zincke, H .
BJU INTERNATIONAL, 2005, 95 (06) :751-756
[80]   Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95 [J].
Wiegel, Thomas ;
Bottke, Dirk ;
Steiner, Ursula ;
Siegmann, Alessandra ;
Golz, Reinhard ;
Stoerkel, Stephan ;
Willich, Norman ;
Semjonow, Axel ;
Souchon, Rainer ;
Stoeckle, Michael ;
Ruebe, Christian ;
Weissbach, Lothar ;
Althaus, Peter ;
Rebmann, Udo ;
Kaelble, Tilman ;
Feldmann, Horst Juergen ;
Wirth, Manfred ;
Hinke, Axel ;
Hinkelbein, Wolfgang ;
Miller, Kurt .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :2924-2930